1. Home
  2. CELU vs DPRO Comparison

CELU vs DPRO Comparison

Compare CELU & DPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • DPRO
  • Stock Information
  • Founded
  • CELU 2016
  • DPRO 1998
  • Country
  • CELU United States
  • DPRO Canada
  • Employees
  • CELU N/A
  • DPRO N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • DPRO Aerospace
  • Sector
  • CELU Health Care
  • DPRO Industrials
  • Exchange
  • CELU Nasdaq
  • DPRO Nasdaq
  • Market Cap
  • CELU 42.2M
  • DPRO 36.2M
  • IPO Year
  • CELU N/A
  • DPRO N/A
  • Fundamental
  • Price
  • CELU $1.98
  • DPRO $3.12
  • Analyst Decision
  • CELU
  • DPRO Strong Buy
  • Analyst Count
  • CELU 0
  • DPRO 2
  • Target Price
  • CELU N/A
  • DPRO $5.25
  • AVG Volume (30 Days)
  • CELU 75.0K
  • DPRO 2.5M
  • Earning Date
  • CELU 05-08-2025
  • DPRO 08-12-2025
  • Dividend Yield
  • CELU N/A
  • DPRO N/A
  • EPS Growth
  • CELU N/A
  • DPRO N/A
  • EPS
  • CELU N/A
  • DPRO N/A
  • Revenue
  • CELU $54,220,000.00
  • DPRO $4,716,450.00
  • Revenue This Year
  • CELU $23.29
  • DPRO $94.01
  • Revenue Next Year
  • CELU N/A
  • DPRO $95.14
  • P/E Ratio
  • CELU N/A
  • DPRO N/A
  • Revenue Growth
  • CELU 138.11
  • DPRO 7.90
  • 52 Week Low
  • CELU $1.00
  • DPRO $1.55
  • 52 Week High
  • CELU $5.22
  • DPRO $6.09
  • Technical
  • Relative Strength Index (RSI)
  • CELU 51.94
  • DPRO 58.98
  • Support Level
  • CELU $1.80
  • DPRO $2.96
  • Resistance Level
  • CELU $2.26
  • DPRO $3.32
  • Average True Range (ATR)
  • CELU 0.18
  • DPRO 0.29
  • MACD
  • CELU 0.02
  • DPRO 0.04
  • Stochastic Oscillator
  • CELU 48.25
  • DPRO 81.48

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About DPRO Draganfly Inc.

Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.

Share on Social Networks: